Lillie James Woodruff Insider Profile
4 Followers
Lillie James Woodruff, CSO at Tempest Therapeutics, holds ― shares in Tempest Therapeutics (Ticker: TPST), holds 298.86K shares in MapLight Therapeutics, Inc. (Ticker: MPLT). Most recently, Lillie James Woodruff ― shares of Tempest Therapeutics on ― for an estimated value of ―.
Lillie James Woodruff has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lillie James Woodruff holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lillie James Woodruff
Lillie James Woodruff's Trading History
Tempest Therapeutics
―
CSO
―
―
MapLight Therapeutics, Inc.
Feb 09, 2026
CSO
Uninformative Buy
―
$8.79M
List of latest transactions for each holding click on a transaction to see Lillie James Woodruff's performance on stock
You May Also Like
Lillie James Woodruff insider profile FAQ
What is the percentage of profitable transactions made by Lillie James Woodruff?
The percentage of profitable transactions made by Lillie James Woodruff is ―.
What is the average return per transaction made by Lillie James Woodruff?
The average return per transaction made by Lillie James Woodruff is ―.
What stocks does Lillie James Woodruff hold?
Lillie James Woodruff holds: TPST, MPLT stocks.
What was Lillie James Woodruff’s latest transaction?
Lillie James Woodruff latest transaction was an Uninformative Buy of ―.
What was Lillie James Woodruff's most profitable transaction?
Lillie James Woodruff’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lillie James Woodruff's role in Tempest Therapeutics?
Lillie James Woodruff's role in Tempest Therapeutics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.